Coverage on (DGII) (HRC) (IMMU) (IRM) (KERX) Initiated

Coverage on Digi International Inc. (NASDAQ: DGII), Hill-Rom Holdings, Inc. (NYSE: HRC), Immunomedics Incorporated (NASDAQ: IMMU), Iron Mountain Incorporated (NYSE: IRM) and Keryx Biopharmaceuticals Inc (NASDAQ: KERX) was initiated by analysts.

Feltl & Co. initiated coverage on Digi International Inc. (DGII). They placed a “buy” rating and a price target of $13.25 on the company.

Goldman Sachs (NYSE:GS) initiated coverage on Hill-Rom Holdings, Inc. (HRC). They placed a “neutral” rating on the company.

Oppenheimer initiated coverage on Immunomedics Incorporated (IMMU). They placed an “outperform” rating and a price target of $6.00 on the company.

Stifel Nicolaus initiated coverage on Iron Mountain Incorporated (IRM). They placed a “buy” rating and a price target of $39.00 on the company.

Oppenheimer initiated coverage on Keryx Biopharmaceuticals Inc (KERX). They placed an “outperform” rating and a price target of $7.00 on the company.